Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1, having proangiogenic activity

Details for Australian Patent Application No. 2007279991 (hide)

International Classifications

Event Publications

19 March 2009 PCT application entered the National Phase

PCT publication WO2008/015720 Priority application(s): WO2008/015720

13 August 2009 Assignment before Grant

Provincia Italiana Della Congregazione Dei Figli Dell'Immacolata Concezione - Istituto Dermopatico Dell'Immacolata; Consiglio Nazionale Delle Ricerche; Universita' Degli Studi Di Roma 'La Sapienza' The application has been assigned to Consiglio Nazionale Delle Ricerche; Provincia Italiana Della Congregazione Dei Figli Dell'Immacolata Concezione - Istituto Dermopatico Dell'Immacolata

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.